from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1493/mutB

LFCtreatmentdescriptionclass of inhibitor

-0.633

Amikacinug/mL Amikacintranslation

-0.782

Cap5-10ug/mL Capreomycintranslation

-0.775

Rox10-50 ug/mL Roxithromycintranslation

0.065

SM2-5 ug/mL Streptomycintranslation

-0.191

Tet5-10 ug/mL Tetracyclinetranslation

-0.603

Rif0.2-5ug/mL Rifampicintranscription

0.193

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.000

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.531

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.121

CPZ10-50 ug/mL Chlorpromazinerespiration

0.000

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.136

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.511

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.406

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.895

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.142

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.399

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.506

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.132

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.543

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.742

KCN5-20 ug/mL Potassium cyaniderespiration

0.638

NaN30.2-2 mM Sodium aziderespiration

-0.213

Nigericin50 uM Nigericinrespiration

0.413

TRC10-150 ug/mL Triclosanrespiration

0.000

TRZ10-25 ug/mL Thioridazinerespiration

0.125

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-1.668

menadione6-10 ug/mL Menadionerespiration

0.428

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.212

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.349

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.418

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.790

NRP_1Non-replicating persistence stage 1dosRassociated

-0.637

Amp0.2mg/mL AmpicillincellWall

0.236

Cephalexin20-100 ug/mL CephalexincellWall

-0.437

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.453

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.229

EMB10-20 ug/mL EthambutolcellWall

0.586

Eta12-40 ug/mL EthionamidecellWall

0.357

INH0.2-0.4 ug/mL IsoniazidcellWall

0.023

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.851

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.000

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

1.333

BZA0.12 mg/mL BenzamidearomaticAmides

0.877

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.790

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.484

H2O24 mM hydrogen peroxideDNAdamaging

-0.541

Levo10 ug/mL LevofloxacinDNAdamaging

-0.636

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.512

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.313

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.626

UVUV-irradiationDNAdamaging

-0.081

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.427

Antimycin12.5-50 ug/mL Antimycin A?

-1.172

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.015

PA_110-50 ug/mL Antitubercular compound PA-1?

0.775

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.038

PA8240.2-2 ug/mL PA-824?

2.374

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.687

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-1.417

Verapamil50 uM Verapamil?

-1.877

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.100

methoxatin10-20 ug/mL Methoxatin?